InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,235.20
(
-0.12%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
-0.72%
)
Bitcoin
64,101.86
(
-1.11%
)
Post# of 21373
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

reaper247

Send PM Follow Ignore
Followers 205
Posts 9810
Boards Moderated 6
Alias Born 10/02/2010

reaper247

Re: namtae post# 18901

Friday, 12/14/2018 1:00:26 AM

Friday, December 14, 2018 1:00:26 AM

Post# of 21373
LOL, namtae…nonsense.

Then again, maybe thats why they moved the testing site to the Ukraine. Is it easier to get through studies there then in SC? (wink wink)



They didn’t move testing to Ukraine, they expanded testing.

From the PR..

...The trials will be conducted in the US as well as sites A and B in the Ukraine...

ONCX has a worldwide patent portfolio for Prolanta. Wouldn’t simple logic dictate that trials be performed in multiple countries?

Always happy to help.

IMO and FWIW.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up